Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin. - Gan HK; Parakh S; Lassman AB; Seow A; Lau E; Lee ST; Ameratunga M; Perchyonok Y; Cao D; Burvenich IJG; O'Keefe GJ; Rigopoulos A; et al. (Neuro-oncology advances, 2021)